Table 3.
Parameter | Abandonment (n=121) | Thrombosis (n=109) | Failure to Cannulate (n=212) | |||
Adjusted OR (95% CI) | P Value | Adjusted OR (95% CI) | P Value | Adjusted OR (95% CI) | P Value | |
Female sex | 2.02 (1.27 to 3.20) | <0.01 | 1.16 (0.72 to 1.89) | 0.54 | 1.74 (1.16 to 2.61) | 0.01 |
Age (per 10 yr) | 1.01 (0.86 to 1.19) | 0.89 | 0.92 (0.77 to 1.08) | 0.30 | 1.12 (0.97 to 1.29) | 0.12 |
Diastolic pressure (per 10 mm Hg) | 0.91 (0.76 to 1.08) | 0.27 | 0.90 (0.75 to 1.07) | 0.23 | 0.80 (0.68 to 0.93) | 0.01 |
Region a | ||||||
Australia/NZ/UK | Ref | 0.66 | Ref | 0.54 | Ref | 0.04 |
Malaysia | 1.18 (0.56 to 2.47) | 1.30 (0.57 to 2.97) | 0.50 (0.26 to 0.98) | |||
Diabetes mellitus | 0.87 (0.54 to 1.39) | 0.55 | 0.70 (0.43 to 1.14) | 0.15 | 0.92 (0.61 to 1.38) | 0.69 |
Presence of PVD | 3.24 (1.31 to 7.98) | 0.01 | 2.46 (0.95 to 6.35) | 0.06 | 0.92 (0.37 to 2.27) | 0.85 |
Presence of CVC | 1.03 (0.65 to 1.61) | 0.91 | 0.77 (0.48 to 1.24) | 0.27 | 1.66 (1.11 to 2.46) | 0.01 |
Use of CCB | 0.91 (0.58 to 1.42) | 0.67 | 0.84 (0.53 to 1.32) | 0.45 | 0.88 (0.60 to 1.29) | 0.51 |
Hemoglobin | 1.00 (0.99 to 1.01) | 0.98 | 1.00 (0.99 to 1.02) | 0.58 | 1.00 (0.99 to 1.01) | 0.48 |
Randomization to aspirin | ||||||
Randomized to placebo | Ref | 0.16 | Ref | 0.26 | Ref | 0.44 |
Randomized to aspirin | 0.71 (0.42 to 1.18) | 0.99 (0.58 to 1.68) | 0.93 (0.60 to 1.43) | |||
Open-label aspirin | 1.19 (0.70 to 2.02) | 1.50 (0.86 to 2.63) | 1.26 (0.78 to 2.03) | |||
Randomization to fish oil use | 1.00 (0.65 to 1.52) | >0.99 | 0.86 (0.56 to 1.33) | 0.50 | 1.13 (0.78 to 1.63) | 0.53 |
AVF type | ||||||
Radiocephalic | Ref | 0.05 | Ref | 0.23 | Ref | 0.04 |
Brachiocephalic | 0.48 (0.29 to 0.81) | 0.60 (0.35 to 1.02) | 0.71 (0.46 to 1.10) | |||
Brachiobasilic | 0.95 (0.41 to 2.19) | 0.56 (0.21 to 1.53) | 2.24 (1.07 to 4.72) | |||
Others | 1.20 (0.20 to 7.15) | 0.66 (0.07 to 5.82) | 0.89 (0.18 to 4.53) | |||
Surgeons | ||||||
Registrar/residents | Ref | 0.54 | Ref | 0.10 | Ref | 0.72 |
Consultant | 0.85 (0.52 to 1.41) | 0.65 (0.40 to 1.08) | 1.08 (0.69 to 1.69) | |||
Anesthesia | ||||||
Regional/general anesthesia | Ref | 0.42 | Ref | 0.48 | Ref | 0.80 |
Local anesthesia | 1.30 (0.69 to 2.45) | 0.78 (0.39 to 1.55) | 1.08 (0.62 to 1.88) |
Single imputation for missing values of individual outcome components was performed and described in detail in the primary outcome analysis (30). AVF, arteriovenous fistula; OR, odds ratio; NZ, New Zealand; UK, United Kingdom; Ref, reference; PVD, peripheral vascular disease; CVC, central venous catheter; CCB, calcium channel blocker.
Australia, New Zealand, and United Kingdom region of recruitment was grouped when compared with Malaysian region of recruitment in this analysis.